New UK study says vaping is up to 98 percent lower in cancer-causing toxins
A new study recently published by a group of UK scientists indicates that switching to vaping from smoking conventional cigarettes can substantially lower the levels of cancer-causing toxins in the body by as much as 98 percent. But there's a catch. Vapers must give up smoking completely. No dual usage is allowed.
The new study was funded by a medical research group named Cancer Research UK, and it is the first of its kind to monitor and evaluate the long-term effects of vaping on the human body. Dr. Lion Shahab from University College London headed the team of scientists who followed a group of 181 participants for an extended period. The participants were divided into five distinct groups.
- Cigarette smokers
- Former smokers now using vaping devices
- Former smokers now using alternative nicotine replacement therapies (NRTs), like “the patch” and nicotine gum.
- Dual users of tobacco cigarettes and vaping technology
- Dual users of tobacco cigarettes and other NRTs
Individual biomarker samples of saliva and urine were collected from each participant on a regular basis. What the scientists concluded is that those who use only vaping devices or only other NRTs had levels of carcinogenic chemicals and toxins in the blood streams that were anywhere from 54 to 97.5 percent lower than the other three groups.
“The take-home message for smokers and e-cigarette users is that using e-cigarettes long-term is likely to carry substantial health benefits, certainly in relation to cancer risk, compared with continued smoking. E-cigarettes are certainly safer than combustible cigarettes.”
-Statement by Dr. Lion Shahab as told to Digital Trends
The American Lung Association weighs in on UK e-cig study
The groundbreaking UK research study was published in early February in the medical journal Annals of Internal Medicine and on the Health Day website. News of the study was also quickly picked up by CBS News who interviewed a Dr. Norman Edelman of the American Lung Association (ALA) as an opponent of the study.
“We don’t know what is in e-cigarette vapor because the devices haven’t yet been fully regulated by the FDA. If you want to stop smoking, you may as well use an FDA-approved nicotine replacement, such as the patch or the lozenge. You can have more confidence because it’s been analyzed by the FDA, while e-cigarettes haven’t been analyzed by the FDA.”
To be clear, the ALA is a long-time opponent of the vaping industry, perhaps because Big Pharma has notoriously funneled billions of dollars to the organization over the years by way of “financial contributions” and “vaping research grant money.” The ALA is deep in the pocket of Big Pharma.
Is it any wonder that Dr. Edelman’s statement to CBS attempts to steer people who want to quit smoking towards FDA-regulated NRTs instead of the more cost-effective vaping solutions? “The Patch, “nicotine gum, nicotine lozenges, and all other types of smoking cessation tools are manufactured and mass-marketed by Big Pharma – the very industry with the most to lose financially if vaping remains loosely regulated by the federal government.